Results 111 to 120 of about 23,251 (254)
Richter Transformation of Chronic Lymphocytic Leukaemia: Biology, Diagnosis, and an Evolving Therapeutic Landscape. [PDF]
Marquet-Palomanes J +2 more
europepmc +1 more source
Australasian chronic lymphocytic leukaemia consensus statement: 2026 update. [PDF]
McKeague S +27 more
europepmc +1 more source
Chronic granulocytic leukaemia and chronic lymphocytic leukaemia. [PDF]
openaire +2 more sources
Summary Most patients treated for chronic lymphocytic leukaemia (CLL) fail to achieve measurable residual disease (MRD) negativity. The role of maintenance with the immunomodulatory drug lenalidomide in these patients is unclear. A randomised multicentre phase III trial (ACTRN12610000060044) was conducted in Australia and France to assess the effect of
Thérèse Aurran‐Schleinitz +45 more
wiley +1 more source
Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience. [PDF]
Duminuco A +21 more
europepmc +1 more source
An Unusual Presentation of Chronic Lymphocytic Leukaemia [PDF]
Kavita Paul +3 more
doaj +1 more source
Baseline immunophenotype and gene expression predict suitability for salvage nivolumab in patients with relapsed/refractory haematological malignancy. Summary Allogeneic haematopoietic stem cell transplantation (alloHSCT) relies on donor‐derived T cells to mediate the graft‐versus‐tumour (GVT) effect, but relapse may result from impaired immune ...
Trung Q. Ngo +7 more
wiley +1 more source
Evolution of the drug sensitivity landscape of chronic lymphocytic leukaemia. [PDF]
Hermansen JU +4 more
europepmc +1 more source

